Feb 24 (Reuters) - CSL Ltd (CSL) :
- SEQIRUS RECEIVES FDA APPROVAL FOR FLUAD® QUADRIVALENT (INFLUENZA VACCINE, ADJUVANTED) FOR ADULTS 65 YEARS AND OLDER
Feb 24 (Reuters) - CSL Ltd (CSL) : SEQIRUS RECEIVES FDA...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.72 |
Change
0.555(0.19%) |
Mkt cap ! $143.3B | |||
| Open | High | Low | Value | Volume |
| $296.30 | $298.20 | $295.64 | $122.4M | 416.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22 | $295.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.72 | 71 | 10 |
View Market Depth
| Last trade - 15.36pm 28/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |